|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23 GBX | -2.13% |
|
-16.67% | -8.73% |
| Feb. 29 | EARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payout | AN |
| Feb. 29 | Oncimmune Holdings plc Provides Earnings Guidance for the Year 2024 | CI |
Oncimmune Holdings plc reported earnings results for the full year ended August 31, 2023. For the full year, the company reported sales was GBP 1.15 million. Net income was GBP 4.1 million.
Basic loss per share from continuing operations was GBP 0.0847. Diluted loss per share from continuing operations was GBP 0.0847. Basic earnings per share was GBP 0.0566.
Diluted earnings per share was GBP 0.0566.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.73% | 21.23M | |
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| +18.82% | 2.38B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B |
ONCIMMUNE HOLDINGS PLC 
